BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8518867)

  • 1. LHRH analogues as primary treatment for urinary retention in patients with prostatic carcinoma.
    Hampson SJ; Davies JH; Charig CR; Shearer RJ
    Br J Urol; 1993 May; 71(5):583-6. PubMed ID: 8518867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of acute urine retention caused by benign prostatic hypertrophy with an LH-RH agonist (Goserelin)].
    Puyol Pallas M; Gómez Parada J
    Actas Urol Esp; 1995 Feb; 19(2):118-22. PubMed ID: 7539571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute urinary retention: a primary manifestation of chronic lymphocytic leukemia and organ confined prostate cancer.
    Ather MH; Memon A
    J Pak Med Assoc; 1999 May; 49(5):124-5. PubMed ID: 10555430
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption.
    Silva J; Silva C; Saraiva L; Silva A; Pinto R; Dinis P; Cruz F
    Eur Urol; 2008 Jan; 53(1):153-9. PubMed ID: 17825981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of transperineal injection of dehydrated ethanol in the treatment of prostatic obstruction.
    Chiang Po; Chuang YC; Huang CC; Chiang CP
    Urology; 2003 Apr; 61(4):797-801. PubMed ID: 12670568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic non-Hodgkin's lymphoma causing acute urinary retention in childhood.
    Li CK; Yeung CK; Chow J; Shing M; Chik KW; Liu K; Yuen P
    Med Pediatr Oncol; 1995 Nov; 25(5):420-2. PubMed ID: 7675001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute urinary retention secondary to carcinoma of the prostate. Is initial channel TURP beneficial?
    Thomas DJ; Balaji VJ; Coptcoat MJ; Abercrombie GF
    J R Soc Med; 1992 Jun; 85(6):318-9. PubMed ID: 1625259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tamsulosin on urinary retention following early catheter removal after robot-assisted laparoscopic radical prostatectomy: a prospective randomized controlled trial.
    Jeong IG; You D; Yoon JH; Hong S; Lim JH; Hong JH; Choo MS; Ahn H; Kim CS
    Int J Urol; 2014 Feb; 21(2):164-8. PubMed ID: 23906190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate.
    Collinson MP; Tyrrel CJ; Hutton C
    Calcif Tissue Int; 1994 Apr; 54(4):327-8. PubMed ID: 8062149
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary retention due to prostatic involvement in testicular lymphoma: a case report.
    Parziani S; Rosi P; Sidoni A; Porena M
    Acta Urol Belg; 1993 Sep; 61(3):33-7. PubMed ID: 8256685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary diffuse large B-cell lymphoma of the prostate presenting as urinary retention.
    Kini JR; Kini H; Pai MR; Naik R
    Indian J Pathol Microbiol; 2010; 53(1):194-5. PubMed ID: 20090277
    [No Abstract]   [Full Text] [Related]  

  • 13. Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer.
    Barry MJ; Kaufman DS; Wu CL
    N Engl J Med; 2008 May; 358(20):2161-8. PubMed ID: 18480209
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study.
    Hagiwara K; Koie T; Iwamura H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
    Biomed Res Int; 2016; 2016():4975851. PubMed ID: 27195288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.
    Axcrona K; Aaltomaa S; da Silva CM; Ozen H; Damber JE; Tankó LB; Colli E; Klarskov P
    BJU Int; 2012 Dec; 110(11):1721-8. PubMed ID: 22500884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol injection therapy for locally invasive prostatic adenocarcinoma.
    Amano H; Goya N; Ryoji O; Yagisawa T; Nakazawa H; Toma H
    Urology; 2002 May; 59(5):771-2. PubMed ID: 11992920
    [No Abstract]   [Full Text] [Related]  

  • 17. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
    Issa MM; Runken MC; Grogg AL; Shah MB
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study.
    Locke J; Ellis W; Wallner K; Cavanagh W; Blasko J
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):712-9. PubMed ID: 11849794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone therapy of prostatic bone metastases.
    Huben RP
    Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-obstructive urinary retention--an unusual presentation of prostate cancer.
    Bandi S; Krishna Sayana M; Ahmed el-N
    Scand J Urol Nephrol; 2005; 39(6):518-9. PubMed ID: 16303730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.